Ferrario, A, Kanavos, P. Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden. Soc Sci Med.. 2014; 124: 39-47 [OpenAIRE] [PubMed] [DOI]
3.WHO. Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research. http://www.euro.who.int/__data/assets/pdf_file/0008/306179/Access-new-medicines-TR-PIO-collaboration-research.pdf?ua=1. Accessed 22 Feb 2017.
Carlson, JJ, Sullivan, SD, Garrison, LP, Neumann, PJ, Veenstra, DL. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between health care payers and manufacturers. Health Policy.. 2010; 96 (3): 179-190 [OpenAIRE] [PubMed] [DOI]
5.Ferrario A, Kanavos P. Managed entry agreements for pharmaceuticals: the European experience. Brussels, Belgium: EMiNet. 2013. http://eprints.lse.ac.uk/50513/1/__Libfile_repository_Content_Ferrario%2C%20A_Ferrario_Managed_%20entry_%20agreements_2013_Ferrario_Managed_%20entry_%20agreements_2013.pdf. Accessed 22 Feb 2017.
Garrison, LJ, Towse, A, Briggs, A, de Pouvourville, G, Grueger, J, Mohr, P. Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force. Value Health.. 2013; 16 (5): 703-719 [OpenAIRE] [PubMed] [DOI]
8.Carlson J, Chen S, Garrison LP Jr. Performance-based risk-sharing arrangements: an updated international review. Pharmacoeconomics. 2017. doi:10.1007/s40273-017-0535-z.
Lu, C, Lupton, C, Rakowsky, S, Babar, Z, Ross-Degnan, D, Wagner, A. Patient access schemes in Asia-pacific markets: current experience and future potential. J Pharm Policy Pract.. 2015; 8 (1): 6 [OpenAIRE] [PubMed] [DOI]
Jarosławski, S, Toumi, M. Design of patient access schemes in the UK: influence of health technology assessment by the National Institute for Health and Clinical Excellence. Appl Health Econ Health Policy.. 2011; 9 (4): 209-215 [OpenAIRE] [PubMed] [DOI]
Towse, A, Garrison, LP. Can’t get no satisfaction? Will pay for performance help? toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products. Pharmacoeconomics.. 2010; 28 (2): 93-102 [OpenAIRE] [PubMed] [DOI]
Garrison, LJ, Carlson, J, Bajaj, P, Towse, A, Neumann, P, Sullivan, S. Private sector risk-sharing agreements in the United States: trends, barriers, and prospects. Am J Manag Care.. 2015; 21 (9): 632-640 [PubMed]
Adamski, J, Godman, B, Ofierska-Sujkowska, G, Osinska, B, Herholz, H, Wendykowska, K. Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers. BMC Health Serv Res.. 2010; 10: 153 [OpenAIRE] [PubMed] [DOI]